Screener
Recursion Pharmaceuticals, Inc. RXRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 603,462 | 812,845 |
| Restricted cash, non-current | 5,752 | 6,033 |
| Property and equipment, net | 89,623 | 103,931 |
| Operating lease right-of-use assets | 40,271 | 45,339 |
| Financing lease right-of-use assets | 17,179 | 20,210 |
| Intangible assets, net | 282,888 | 309,903 |
| Goodwill | 160,350 | 162,158 |
| Deferred tax assets | 957 | 957 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease ROU assets of $40.27M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 20.0% year-over-year, from $50.32M to $40.27M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 8.3% compound annual growth rate (CAGR), from $32.9M to $45.34M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude